当前位置: X-MOL 学术Crit. Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Critical Care ( IF 8.8 ) Pub Date : 2024-11-26 , DOI: 10.1186/s13054-024-05123-7
Matthieu Legrand, Ashish K. Khanna, Marlies Ostermann, Yuki Kotani, Ricard Ferrer, Massimo Girardis, Marc Leone, Gennaro DePascale, Peter Pickkers, Pierre Tissieres, Filippo Annoni, Katarzyna Kotfis, Giovanni Landoni, Alexander Zarbock, Patrick M. Wieruszewski, Daniel De Backer, Jean-Louis Vincent, Rinaldo Bellomo

Dysregulation of the renin–angiotensin–aldosterone-system (RAAS) in sepsis is a complex and early phenomenon with a likely significant contribution to organ failure and patient outcomes. A better understanding of the pathophysiology and intricacies of the RAAS in septic shock has led to the use of exogenous angiotensin II as a new therapeutic agent. In this review, we report a multinational and multi-disciplinary expert panel discussion on the role and implications of RAAS modulation in sepsis and the use of exogenous angiotensin II. The panel proposed guidance regarding patient selection and treatment options with exogenous angiotensin II which should trigger further research.

中文翻译:


脓毒症中的肾素-血管紧张素-醛固酮系统及其与外源性血管紧张素 II 的临床调节



脓毒症中肾素-血管紧张素-醛固酮系统 (RAAS) 失调是一种复杂的早期现象,可能对器官衰竭和患者预后有重大影响。对感染性休克中 RAAS 的病理生理学和复杂性的更好理解导致使用外源性血管紧张素 II 作为新的治疗剂。在这篇综述中,我们报告了一个多国和多学科专家小组讨论,讨论了 RAAS 调节在脓毒症中的作用和影响以及外源性血管紧张素 II 的使用。该小组提出了有关外源性血管紧张素 II 的患者选择和治疗方案的指南,这应该会引发进一步的研究。
更新日期:2024-11-26
down
wechat
bug